Basilea Pharmaceutica AG
Stock Forecast, Prediction & Price Target
Basilea Pharmaceutica AG Financial Estimates
Basilea Pharmaceutica AG Revenue Estimates
Basilea Pharmaceutica AG EBITDA Estimates
Basilea Pharmaceutica AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF148.12M N/A | CHF147.76M -0.24% | CHF157.63M 6.67% | Avg: CHF191.80M Low: CHF191.80M High: CHF191.80M avg. 21.67% | Avg: CHF223.49M Low: CHF223.49M High: CHF223.49M avg. 16.52% | Avg: CHF223.31M Low: CHF223.31M High: CHF223.31M avg. -0.07% | Avg: CHF204.34M Low: CHF204.34M High: CHF204.34M avg. -8.49% |
Net Income
% change YoY
| CHF-6.83M N/A | CHF12.14M 277.82% | CHF10.45M -13.96% | Avg: CHF23.32M Low: CHF23.32M High: CHF23.32M avg. 123.14% | Avg: CHF44.72M Low: CHF44.72M High: CHF44.72M avg. 91.79% | Avg: CHF73.04M Low: CHF73.04M High: CHF73.04M avg. 63.30% | Avg: CHF79.65M Low: CHF79.65M High: CHF79.65M avg. 9.06% |
EBITDA
% change YoY
| CHF3.62M N/A | CHF19.44M 436.12% | CHF23.18M 19.26% | Avg: CHF761.53K Low: CHF761.53K High: CHF761.53K avg. -96.71% | Avg: CHF887.34K Low: CHF887.34K High: CHF887.34K avg. 16.52% | Avg: CHF886.64K Low: CHF886.64K High: CHF886.64K avg. -0.07% | Avg: CHF811.34K Low: CHF811.34K High: CHF811.34K avg. -8.49% |
EPS
% change YoY
| -$0.58 N/A | $1.02 275.86% | $0.87 -14.70% | Avg: $1.92 Low: $1.92 High: $1.92 avg. 120.74% | Avg: $3.68 Low: $3.68 High: $3.68 avg. 91.79% | Avg: $6.02 Low: $6.02 High: $6.02 avg. 63.30% | Avg: $6.56 Low: $6.56 High: $6.56 avg. 9.06% |
Operating Expenses
% change YoY
| CHF122.87M N/A | CHF104.61M -14.85% | CHF111.63M 6.70% | Avg: CHF41.33M Low: CHF41.33M High: CHF41.33M avg. -62.96% | Avg: CHF48.16M Low: CHF48.16M High: CHF48.16M avg. 16.52% | Avg: CHF48.13M Low: CHF48.13M High: CHF48.13M avg. -0.07% | Avg: CHF44.04M Low: CHF44.04M High: CHF44.04M avg. -8.49% |
FAQ
What is Basilea Pharmaceutica AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 71.82% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 23.32M, average is 23.32M and high is 23.32M.
What is Basilea Pharmaceutica AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 7.40% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is CHF191.80M, average is CHF191.80M and high is CHF191.80M.
What is Basilea Pharmaceutica AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 71.22% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $1.92, average is $1.92 and high is CHF1.92.